The MAO inhibitor phenelzine improves functional outcomes in mice with experimental autoimmune encephalomyelitis (EAE)-Reference-Cited by-同舟云学术

The MAO inhibitor phenelzine improves functional outcomes in mice with experimental autoimmune encephalomyelitis (EAE)

Published:2011-11 Issue:8 Volume:25 Page:1677-1688
ISSN:0889-1591
Container-title:Brain, Behavior, and Immunity
language:en
Short-container-title:Brain, Behavior, and Immunity

Author:

Musgrave Travis,Benson Curtis,Wong Grace,Browne Ikennah,Tenorio Gustavo,Rauw Gail,Baker Glen B.,Kerr Bradley J.

Publisher

Elsevier BV

Subject

Behavioral Neuroscience,Endocrine and Autonomic Systems,Immunology

Reference66 articles.

1. Rat brain concentrations of 5-hydroxytryptamine following acute and chronic administration of MAO-inhibiting antidepressants;Baker;Prog. Neuropsychopharmacol. Biol. Psychiatry,1984

2. Effects of the antidepressant phenelzine on brain levels of gamma-aminobutyric acid (GABA);Baker;J. Affect. Disord.,1991

3. Amine oxidases and their inhibitors: what can they tell us about neuroprotection and the development of drugs for neuropsychiatric disorders?;Baker;J. Psychiatry Neurosci.,2007

4. Differential regulation of central BDNF protein levels by antidepressant and non-antidepressant drug treatments;Balu;Brain Res.,2008

5. Use-dependent regulation of GABAA receptors;Barnes;Int. Rev. Neurobiol.,1996

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Flecainide enhances blood-brain barrier function: Novel mode of action of sodium channel blocking in experimental autoimmune encephalomyelitis (EAE);2024-08-28

2. Chemogenetic activation of locus coeruleus neurons ameliorates the severity of multiple sclerosis;Journal of Neuroinflammation;2023-09-01

3. Chronic Effects of the Sympathetic Nervous System in Inflammatory Models;Neuroimmunomodulation;2023

4. Antidepressants as a potential candidate to reduce microglia activation in neurodegenerative diseases. A systematic review and meta-analysis of preclinical studies;Journal of Affective Disorders Reports;2023-01

5. Combining monoamine oxidase B and semicarbazide-sensitive amine oxidase enzyme inhibition to address inflammatory disease;Bioorganic & Medicinal Chemistry Letters;2022-10